Gut Inflammatory Diseases, Infection, and NutritionView this Special Issue
Research Article | Open Access
G. S. A. Boersema, Z. Wu, A. G. Menon, G. J. Kleinrensink, J. Jeekel, J. F. Lange, "Systemic Inflammatory Cytokines Predict the Infectious Complications but Not Prolonged Postoperative Ileus after Colorectal Surgery", Mediators of Inflammation, vol. 2018, Article ID 7141342, 9 pages, 2018. https://doi.org/10.1155/2018/7141342
Systemic Inflammatory Cytokines Predict the Infectious Complications but Not Prolonged Postoperative Ileus after Colorectal Surgery
Aim. Postoperative ileus (POI) is common after surgery. Animal studies indicate that the POI mechanism involves an inflammatory response, which is also activated during postoperative complications. This study aimed to determine whether inflammatory biomarkers might facilitate an early detection of prolonged POI (PPOI) or infectious complications. Methods. Forty-seven adult patients who underwent oncological colorectal surgery were included. They filled out a perioperative diary to report their gastrointestinal symptoms. Blood samples were collected preoperatively, and on postoperative day (POD) 1 and 3. Levels of leucocytes, C-reactive protein (CRP), interleukin (IL)-6, TNF-α, and IL-1β were analyzed. Results. Patients with PPOI had significantly longer stay in hospital than patients without (13.6 ± 10.5 versus 7.4 ± 3.2 days, ); they also had higher levels of IL-6 ratios, leucocytes, and CRP levels, but did not reach significance. Higher levels of postoperative IL-6 and CRP levels (, resp.) were found in patients with infectious complications. The receiver operating characteristic (ROC) analysis found better diagnostic values of IL-6 ratio on both POD 1 and 3 than that of CRP (POD 1: ROC 0.825, ). Conclusion. Blood levels of inflammatory cytokines cannot predict PPOI after colorectal surgery. Instead, postoperative IL-6 changes may predict the infectious complications with a better diagnostic value than the current leukocytes or CRP tests.
Surgical resection is still the cornerstone of colorectal cancer treatment. Nevertheless, colorectal surgery is associated with a high morbidity rate of 24–43% [1–3], which significantly compromises a fast recovery after surgery and quality of life after discharge. Infectious complications including surgical site infection and anastomotic leakage are the major causes of postoperative morbidity and mortality . Moreover, many patients also develop postoperative ileus (POI) characterized by a transient impairment of bowel function and reduced motility. In some of them, prolonged POI (PPOI) is diagnosed when POI does not resolve after 5 postoperative days or recurs after an apparent resolution. Such delayed recovery of bowel function leads to other serious outcomes such as longer hospitalization, hospital-acquired infections, pulmonary compromise, and a large increase of medical cost as well .
Many studies on animal models have revealed that the mechanism of POI includes an inflammatory response caused by the intestinal manipulation and surgical trauma [6–8]. Therefore, inflammatory markers such as interleukin (IL)-1β, IL-6, TNF-α, and C-reactive protein (CRP) have been suggested to be valuable for the early detection of POI. Previous studies reported that the levels of IL-1β, IL-6, and TNF-α in PPOI patients were significantly higher at postoperative day 5 in abdominal drain fluid than that in normal recoveries [9, 10]. However, due to the wide application of the ERAS (enhanced recovery after surgery) program, peritoneal drainage is no longer routine practice in colorectal patients. In such cases, measuring systematic levels of the inflammatory cytokines seems to be a promising alternative since it can be easily integrated into postoperative blood tests.
This approach is supported by animal studies, which have revealed that elevation of the inflammatory cytokines is also detectable in blood samples in addition to a localized change [6, 7]. Nevertheless, clinical data to support this are still not yet available. Moreover, it is important to note that the classic proinflammatory response is also activated in infectious complications, and increasing levels of the inflammatory cytokines were also reported in these complications [11–16]. To this end, we conducted a prospective cohort study in patients underwent colorectal surgery. In this study, we analyzed the systemic inflammatory markers in perioperative blood samples. The primary goal of this study was to investigate whether the perioperative inflammatory cytokine levels can predict PPOI. Secondarily, we also tried to associate the cytokine levels with the infectious complications.
2.1. Study Population and Design
Adult patients admitted to the Academic Colorectal Cancer Center, Havenziekenhuis, Rotterdam, who underwent oncological colorectal surgery, were included after informed consent. In total, 50 patients were planned to be included in this prospective cohort during the period of November 2013 and November 2014. In accordance with the Dutch law on medical research in humans, this study was approved by the Medical Ethical Committee of the Erasmus University Medical Center, Rotterdam, Netherlands (permit number: MEC-2013-246, NL43053.078.13) and patients gave their written consent after receiving oral and written information.
All patients were asked to fill out a questionnaire before surgery and every day after surgery until postoperative day (POD) 7. The questions refer to their food and fluid intake, bowel movements and defecation, gastrointestinal symptoms, and visual analogue scale (VAS) pain score. Data collection included age, gender, body mass index (BMI), American Society of Anesthesiologists (ASA) score, medication use, smoking, operative procedure, and postoperative complications including anastomotic leakage, fascia dehiscence, surgical site infection (SSI), urinary tract infection, pneumonia, and postoperative course.
2.2. Selection of Variables and Definitions
To ensure the objectivity of the primary endpoint, PPOI was not diagnosed by the participating surgeons but via the retrospective review of the patient diary and medical record. The participating doctors diagnosed the other complications based on the criteria referred from the literature [17–19] (see Table 1).
Prolonged postoperative ileus.
2.3. Blood Sample Analysis
Peripheral blood was drawn from each patient before surgery (baseline) and on the first and third postoperative days in the morning, together with the routine blood tests. Leucocytes and CRP measurements were part of the standardized care and the outcomes were retrieved from the medical chart. Blood samples were centrifuged and plasma was stored at −80°C into two aliquots for each sample. Enzyme-linked immunosorbent assays (ELISAs) were performed according to manufacturer’s instructions to quantify the concentrations of systematic inflammatory markers IL-6 and TNF-α (PeproTech Inc., Rocky Hill, USA) and IL-1β (R&D Systems, Minneapolis, MN, USA) in blood plasma.
2.4. ERAS Protocol
All patients were treated according to the ERAS protocol. Two hours before surgery patients preoperatively received a carbohydrate-loaded drink. In some cases of low anterior resection, an enema was given under prescription of the surgeon. In general, left-sided colectomy and (low) anterior resections received bowel preparation with 2 liters of Macrogol 3350 (Klean-Prep 69 gr, Norgine Ltd., Harefield, United Kingdom). Immediately after surgery, nasogastric tubes were removed and patients are allowed to move or drink fluid food. Normal diet was offered from the first postoperative day and so on.
2.5. Statistical Analysis
The statistical analysis was carried out using the Statistical Package for the Social Sciences (SPSS Inc., Chicago, USA, version 21.0 for Windows). Demographic data were presented in n (%), mean (SD), or median (95% confidence interval). Mann–Whitney U test, chi-square test, Pearson correlation test, and receiver operating characteristic (ROC) analysis were employed according to a proper indication. A 2-tailed value < 0.05 was considered to indicate statistical significance.
Between October 2013 and November 2014, 54 patients were included. Among them, three patients were excluded because of protocol violations of the inclusion criteria, and four patients retracted the informed consent. In total, 47 patients were included for analysis.
3.1. PPOI versus Non-PPOI
In total, 72% (34/47) of the patients recovered from POI within five postoperative days (POD 5) and were assigned to the non-PPOI group; 28% (13/47) patients recovered on or after 6 days postoperatively (8/13) or had recurrence of POI (5/13) and were therefore defined as PPOI. Univariate analysis showed a similar baseline and operative characteristics in the patients with or without PPOI (Table 2).
PPOI = prolonged postoperative ileus; non-PPOI = patients without PPOI. Data are n (%), mean (SD). BMI = body mass index; ASA = American Society of Anesthesiologists classification; COPD = chronic obstructive pulmonary disease; # in non-PPOI, in PPOI group; in non-PPOI group, in PPOI group; in PPOI group.
IL-6 levels were detectable and measurable in all the samples. However, TNF-α and IL-1β were not detectable in the majority of samples. The detailed proportions of detectable samples are listed in Supplementary Table S1.
The absolute median values of cytokines of positive samples are presented in Supplementary Table S2. In the detected samples, we found several samples with substantially higher levels of cytokines compared with other samples, resulting in a large variation in results. We also found that cytokine levels of these patients remained high after surgery. Therefore, a cytokine ratio was calculated with the following equation: for further analysis. Cytokine levels and ratios describe the ratio of cytokine levels at postoperative days 1 and 3 divided by the preoperative cytokine level.
The PPOI group showed higher IL-6 ratios on POD 3: 5.90 ± 9.11 than in the non-PPOI group: 2.44 ± 3.84 (Figure 1). Due to a low number of valid values, we found no differences in IL-1β ratio and TNF-α ratio between the two groups.
Both leucocytes and CRP were higher in the PPOI group, but there were no significantly differences between non-PPOI and PPOI groups at any time point (Figure 2). Also, a higher postoperative VAS score was seen in the PPOI group, though no statistical difference was observed.
In total, 13.0% (6/46) were diagnosed with colorectal anastomotic leakage. In the PPOI group, a significantly higher percentage of anastomotic leakage was seen, 38.5% (5/13) versus 3.0% (1/33) in the non-PPOI group, . The hospital stay duration was significant longer in PPOI patients 13.6 ± 10.5 versus 7.4 ± 3.2 in the non-PPOI cases, (Figure 2(d)).
3.2. Infectious versus Non-Infectious Complication
There were no significant differences between the baseline and surgical characteristic comparison of patients with and without infectious complications (Supplementary Table S3). Different from the PPOI patients, patients with the infectious complications had significantly higher IL-6 ratios and CRP levels on POD 1 and POD 3 (, respectively, Figure 3(a)), while the leucocyte count, though also higher, was not significantly different from patients without infectious complications, Figure 3(c). Further detailed analysis showed that significantly higher levels of IL-6 ratios on POD 1 and POD 3 were found in SSI and colorectal anastomotic leakage (CAL) patients as illustrated in Figure 3(a), while the differences in CRP were not significant (Figure 3(b)). No differences were observed in IL-1β and TNF-α ratios between the groups.
We performed the ROC analysis to determine the diagnostic value of CRP and IL-6 ratio in detection of infectious complications. Both on POD 1 and POD 3, IL-6 ratio had a larger area under curve (AUC) than that of CRP (Figure 4). Further analysis showed that the diagnostic value was achieved on POD 1 with a cutting-off point of 1.21 of IL-6 ratio, which yielded a sensitivity of 76% and a specificity of 86%. Although the sensitivity was relatively low (43%), a cutting-off point of 1.93 on POD 1 reached a specificity of 100%, meaning all patients with an IL-6 ratio higher than 1.93 on POD 1 were diagnosed with infectious complications later on.
The importance of developing effective strategies to predict and eventually to treat the postoperative complications cannot be overemphasized . In this study, we investigated the association between the inflammatory cytokines and the postoperative complications. We found that systematic changes of IL-6 predicted the infectious complications but not prolonged POI after colorectal surgery.
To develop the effective strategies, researchers depend on the translational knowledge from animal studies, which have been continuously contributing to the understanding of POI mechanism. Several experimental studies have reported the important role of IL-6 in the development of POI. Even little manipulation of the bowel induces activity of IL-6, which results in activation of nitric oxide and prostaglandins and causes migration of leucocytes into the circular muscle of the bowel and ends up with PPOI eventually [21–24]. However, with fruitful data obtained from animal studies, clinical attempts to predict POI by determining inflammatory mediator levels, the important mechanism in PPOI pathophysiology, remain limited. Zhu et al. found that peritoneal levels of IL-1, IL-6, and procalcitonin were higher in PPOI patients , indicating localized parameters are sensitive for PPOI prediction. Clinical data also found that IL-6 levels are higher in patients undergoing open surgery when compared with patients undergoing laparoscopic surgery , while open procedures had been demonstrated to delay recovery of POI .
In this study, we report a prospective cohort investigating the association between the inflammatory cytokines and the postoperative complications. We found that systematic changes of IL-6 predicted infectious complications but did not predict PPOI after colorectal surgery. In contrast to many previous animal studies, our results indicate that systematic cytokine levels yield poor predictive value in PPOI diagnosis. This can be partly explained by inevitable confounding factors (e.g., sex, age, type of surgery, and preoperative risk factors) in patient subjects which dilute the influence of POI on systematic inflammatory response , while those factors are usually controlled in animal studies. Nevertheless, we believe that our included patients properly represent the common colorectal patient population. An ideal parameter should be able to identify the high-risk patients. In addition, many animal models used in POI research have very different inflammatory response compared with human [26, 27]. For instance, different from the animal data, our study found that systematic TNF-α and IL-1β levels were extremely low, which was also reported by Ellebæk et al. . In addition, our previous meta-analysis also found that in peritoneal samples, IL-6 is already significantly higher in CAL patients on POD 1, while elevation of TNF-α and IL-1β, both at much lower concentration, was not observed in the first 3 postoperative days .
As is shown in our results, cytokine levels are individually dependent. This has not yet been previously investigated in surgical patients. Picotte et al. also reported great variation in systematic IL-6 levels ; therefore, we chose ratio instead of absolute levels of cytokines to rule out the individual baseline variations, which resulted in a higher diagnostic value of the infectious complications than CRP in the ROC analysis.
Based on our results, it seems that only in severe complications but not PPOI can the overwhelming inflammatory response be detected in serum in clinical settings. For those complications, leukocyte count and CRP are commonly used to assist an early diagnosis [31, 32]; thus, we also included them into our analysis. In accordance to the previous studies, our data also support the value of CRP in the diagnosis of infectious complications. Nevertheless, the ROC analysis further demonstrates that IL-6 yielded better diagnostic value than CRP in predicting the infectious complications. It is important to note that the diagnostic value of IL-6 became evident very early on POD 1. All patients had a ratio higher than 1.93 developed infectious complications, indicating the importance of IL-6 evaluation as a promising innovative biomarker for clinical practice.
Although many previous studies exclude patients with other complications from the PPOI group, we still included them to represent a common patient population. This is because it is possible to exclude those patients with complications (e.g., anastomotic leakage) from the POI or PPOI group in a retrospective database. But in a prospective cohort or clinical practice, a surgeon has to differentiate POI or PPOI from other severe complications that require more invasive interventions because many infectious complications first manifest abdominal symptoms before systematic manifestations. This may explain the significantly higher rate of the complications in the PPOI patients in our data.
POI remains the most common complication after gastrointestinal surgery, without a satisfactory parameter for its early detection or prediction. In this study, we report a prospective cohort study investigating the association between inflammatory cytokines and postoperative complications. We found that serum IL-6 changes predict the infectious complications but not PPOI after colorectal surgery. How to translate knowledge from rodent POI studies to clinical practice is evidently an urgent issue to be addressed. Further exploration of IL-6 seems promising and may assist an early detection of the infectious complications after surgery.
G. S. A. Boersema and Z. Wu should both be considered the first authors. This study was presented to the European Colorectal Congress, St. Gallen, Switzerland, December, 2016.
Conflicts of Interest
The authors declare no conflict of interest.
J. F. Lange, J. Jeekel, G. J. Kleinrensink, A. G. Menon, Z. Wu, and G. S. A. Boersema designed the research; G. S. A. Boersema and Z. Wu performed the research; G. S. A. Boersema and Z. Wu analyzed the data; G. S. A. Boersema, Z. Wu, and J. F. Lange wrote the article, and all authors drafted the article or revised it critically for important intellectual content and approved the current version. G. S. A. Boersema and Z. Wu contributed equally to designing and performing the trial, data interpretation, and writing of the manuscript.
The authors would like to thank all medical assistance from the Academic Colorectal Cancer Center, Havenziekenhuis, Rotterdam, for their help. This study was funded by “Stichting Coolsingel”, Rotterdam; Beijing Municipal Science and Technology Project, Beijing Municipal Science and Technology Commission (D141100000414004); and Program for Clinical Application and Development, Beijing Municipal Science and Technology Commission (Z151100004015070).
Table S1: percentage of positive samples in the non-PPOI and PPOI group. Table S2: absolute level of cytokine in plasma of the positive samples. Table S3: baseline and surgical characteristic comparison between patients with infectious complications and normal recovery. (Supplementary Materials)
- A. Alves, Y. Panis, P. Mathieu et al., “Mortality and morbidity after surgery of mid and low rectal cancer: results of a French prospective multicentric study,” Gastroentérologie Clinique et Biologique, vol. 29, no. 5, pp. 509–514, 2005.
- A. Alves, Y. Panis, P. Mathieu et al., “Postoperative mortality and morbidity in french patients undergoing colorectal surgery: results of a prospective multicenter study,” Archives of Surgery, vol. 140, no. 3, pp. 278–283, 2005.
- A. Alves, Y. Panis, K. Slim et al., “French multicentre prospective observational study of laparoscopic versus open colectomy for sigmoid diverticular disease,” The British Journal of Surgery, vol. 92, no. 12, pp. 1520–1525, 2005.
- P. Kirchhoff, P. A. Clavien, and D. Hahnloser, “Complications in colorectal surgery: risk factors and preventive strategies,” Patient Safety in Surgery, vol. 4, no. 1, p. 5, 2010.
- R. Schuster, N. Grewal, G. C. Greaney, and K. Waxman, “Gum chewing reduces ileus after elective open sigmoid colectomy,” Archives of Surgery, vol. 141, no. 2, pp. 174–176, 2006.
- J. C. Kalff, W. H. Schraut, R. L. Simmons, and A. J. Bauer, “Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus,” Annals of Surgery, vol. 228, no. 5, pp. 652–663, 1998.
- A. Turler, B. A. Moore, M. A. Pezzone, M. Overhaus, J. C. Kalff, and A. J. Bauer, “Colonic postoperative inflammatory ileus in the rat,” Annals of Surgery, vol. 236, no. 1, pp. 56–66, 2002.
- A. J. Bauer and G. E. Boeckxstaens, “Mechanisms of postoperative ileus,” Neurogastroenterology & Motility, vol. 16, no. S2, pp. 54–60, 2004.
- P. Zhu, Z. Liang, J. Fu et al., “Procalcitonin in abdominal exudate to predict prolonged postoperative ileus following colorectal carcinoma surgery,” The International Journal of Biological Markers, vol. 28, no. 2, pp. 187–191, 2013.
- P. Zhu, H. Jiang, J. Fu, W. Chen, Z. Wang, and L. Cui, “Cytokine levels in abdominal exudate predict prolonged postoperative ileus following surgery for colorectal carcinoma,” Oncology Letters, vol. 6, no. 3, pp. 835–839, 2013.
- T. C. D. Rettig, L. Verwijmeren, I. M. Dijkstra, D. Boerma, E. M. W. van de Garde, and P. G. Noordzij, “Postoperative interleukin-6 level and early detection of complications after elective major abdominal surgery,” Annals of Surgery, vol. 263, no. 6, pp. 1207–1212, 2016.
- I. Dimopoulou, A. Armaganidis, E. Douka et al., “Tumour necrosis factor-alpha (TNFα) and interleukin-10 are crucial mediators in post-operative systemic inflammatory response and determine the occurrence of complications after major abdominal surgery,” Cytokine, vol. 37, no. 1, pp. 55–61, 2007.
- D. Mokart, M. Merlin, A. Sannini et al., “Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery,” British Journal of Anaesthesia, vol. 94, no. 6, pp. 767–773, 2005.
- H. Korner, H. J. Nielsen, J. A. Soreide, B. S. Nedrebo, K. Soreide, and J. C. Knapp, “Diagnostic accuracy of C-reactive protein for intraabdominal infections after colorectal resections,” Journal of Gastrointestinal Surgery, vol. 13, no. 9, pp. 1599–1606, 2009.
- P. Matthiessen, M. Henriksson, O. Hallbook, E. Grunditz, B. Noren, and G. Arbman, “Increase of serum C-reactive protein is an early indicator of subsequent symptomatic anastomotic leakage after anterior resection,” Colorectal Disease, vol. 10, no. 1, pp. 75–80, 2008.
- Y. Takakura, T. Hinoi, H. Egi et al., “Procalcitonin as a predictive marker for surgical site infection in elective colorectal cancer surgery,” Langenbeck's Archives of Surgery, vol. 398, no. 6, pp. 833–839, 2013.
- R. Vather, S. Trivedi, and I. Bissett, “Defining postoperative ileus: results of a systematic review and global survey,” Journal of Gastrointestinal Surgery, vol. 17, no. 5, pp. 962–972, 2013.
- N. N. Rahbari, J. Weitz, W. Hohenberger et al., “Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer,” Surgery, vol. 147, no. 3, pp. 339–351, 2010.
- A. Artinyan, J. W. Nunoo-Mensah, S. Balasubramaniam et al., “Prolonged postoperative ileus—definition, risk factors, and predictors after surgery,” World Journal of Surgery, vol. 32, no. 7, pp. 1495–1500, 2008.
- S. ter Hoeve-Boersema, Major Abdominal Surgical Complications: Innovative Approaches, [Ph.d. thesis], Erasmus University Rotterdam, Rotterdam, Netherlands, 2017.
- R. Frasko, P. Maruna, R. Gurlich, and S. Trca, “Transcutaneous electrogastrography in patients with ileus. Relations to interleukin-1β, interleukin-6, procalcitonin and C-reactive protein,” European Surgical Research, vol. 41, no. 2, pp. 197–202, 2008.
- M. Overhaus, S. Togel, M. A. Pezzone, and A. J. Bauer, “Mechanisms of polymicrobial sepsis-induced ileus,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 287, no. 3, pp. G685–G694, 2004.
- H. Törnblom, H. Abrahamsson, G. Barbara et al., “Inflammation as a cause of functional bowel disorders,” Scandinavian Journal of Gastroenterology, vol. 40, no. 10, pp. 1140–1148, 2005.
- S. Wehner, N. T. Schwarz, R. Hundsdoerfer et al., “Induction of IL-6 within the rodent intestinal muscularis after intestinal surgical stress,” Surgery, vol. 137, no. 4, pp. 436–446, 2005.
- Z. Wu, G. S. A. Boersema, A. Dereci, A. G. Menon, J. Jeekel, and J. F. Lange, “Clinical endpoint, early detection, and differential diagnosis of postoperative ileus: a systematic review of the literature,” European Surgical Research, vol. 54, no. 3-4, pp. 127–138, 2015.
- A. C. Drake, “Of mice and men: what rodent models don’t tell us,” Cellular & Molecular Immunology, vol. 10, no. 4, pp. 284-285, 2013.
- J. Seok, H. S. Warren, A. G. Cuenca et al., “Genomic responses in mouse models poorly mimic human inflammatory diseases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 9, pp. 3507–3512, 2013.
- M. B. Ellebæk, G. Baatrup, J. Gjedsted, C. Fristrup, and N. Qvist, “Cytokine response in peripheral blood indicates different pathophysiological mechanisms behind anastomotic leakage after low anterior resection: a pilot study,” Techniques in Coloproctology, vol. 18, no. 11, pp. 1067–1074, 2014.
- C. L. Sparreboom, Z. Wu, A. Dereci et al., “Cytokines as early markers of colorectal anastomotic leakage: a systematic review and meta-analysis,” Gastroenterology Research and Practice, vol. 2016, Article ID 3786418, 11 pages, 2016.
- M. Picotte, C. G. Campbell, and W. G. Thorland, “Day-to-day variation in plasma interleukin-6 concentrations in older adults,” Cytokine, vol. 47, no. 3, pp. 162–165, 2009.
- T. Welsch, S. A. Müller, A. Ulrich et al., “C-reactive protein as early predictor for infectious postoperative complications in rectal surgery,” International Journal of Colorectal Disease, vol. 22, no. 12, pp. 1499–1507, 2007.
- P. Ortega-Deballon, F. Radais, O. Facy et al., “C-reactive protein is an early predictor of septic complications after elective colorectal surgery,” World Journal of Surgery, vol. 34, no. 4, pp. 808–814, 2010.
Copyright © 2018 G. S. A. Boersema et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.